Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-11-01
Edice:Cell & Bioscience
Témata:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
On-line přístup:http://link.springer.com/article/10.1186/s13578-020-00492-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky